2 years ago
SYRE
AnalystsYanan ZhuYanan Zhu's Stock Forecasts
AnalystsYanan Zhu
Sectors:
Analyst Ranking
Top 27%
#1350 out of 5020 analysts
Average Return
+3.35%
Win Rate
41%32 out of 78
Risk vs Reward
Poor
Good
Yanan Zhu's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Regulus Therapeutics IncRGLS | +423.33% | $1.50 | $7.85 | 2025-03-27 - 2025-05-01 | Strong Buy |
Gracell Biotechnologies IncGRCL | +422.11% | $1.90 | $9.92 | 2023-03-27 - 2023-12-27 | Strong Buy |
Autolus Therapeutics PLCAUTL | +233.51% | $1.85 | $6.17 | 2023-03-27 - 2024-03-26 | Strong Buy |
Avidity Biosciences IncRNA | +226.15% | $9.56 | $31.18 | 2024-01-03 - 2025-01-02 | Strong Buy |
Avidity Biosciences IncRNA | +131.99% | $11.19 | $25.96 | 2023-05-11 - 2024-05-10 | Strong Buy |
Yanan Zhu Analyst Color
Get additional color on Yanan Zhu's coverage of popular stocks
2 years ago
IOVA
2 years ago
IOVA
2 years ago
BLUE
Yanan Zhu's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Editas Medicine IncEDIT | 7 | Hold | $4.00 | +47.06% | Maintains | 16 days ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | $45.00 | +83.75% | Initiates Coverage On | 25 days ago |
Ionis Pharmaceuticals IncIONS | 3 | Strong Buy | $82.00 | +34.05% | Maintains | a month ago |
Metagenomi IncMGX | 4 | Strong Buy | $12.00 | +538.30% | Maintains | a month ago |
Taysha Gene Therapies IncTSHA | 3 | Strong Buy | $8.00 | +175.86% | Maintains | a month ago |
Fate Therapeutics IncFATE | 4 | Hold | $2.50 | +163.16% | Maintains | a month ago |
Autolus Therapeutics PLCAUTL | 4 | Strong Buy | $5.00 | +293.70% | Maintains | a month ago |
Arcturus Therapeutics Holdings IncARCT | 7 | Strong Buy | $42.00 | +132.69% | Maintains | a month ago |
Rapt Therapeutics IncRAPT | 5 | Strong Buy | $38.00 | +111.11% | Maintains | a month ago |
Iovance Biotherapeutics IncIOVA | 5 | Strong Buy | $14.00 | +530.63% | Maintains | a month ago |
Intellia Therapeutics IncNTLA | 5 | Strong Buy | $45.00 | +262.61% | Maintains | a month ago |
Avidity Biosciences IncRNA | 4 | Strong Buy | $75.00 | +87.22% | Maintains | a month ago |
Sarepta Therapeutics IncSRPT | 6 | Strong Buy | $50.00 | +193.26% | Maintains | a month ago |
Adaptimmune Therapeutics PLCADAP | 3 | Hold | $1.00 | +1,134.57% | Maintains | 4 months ago |
Affimed NvAFMDQ | 7 | Hold | $0.10 | -44.75% | Downgrades | 4 months ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $70.00 | +211.80% | Maintains | 4 months ago |
Regulus Therapeutics IncRGLS | 2 | Hold | $9.00 | +10.29% | Downgrades | 5 months ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | $10.00 | +134.74% | Maintains | 6 months ago |
Uniqure NvQURE | 2 | Hold | $30.00 | +111.86% | Maintains | 7 months ago |
Bluebird Bio IncBLUE | 7 | Hold | $5.00 | +0.60% | Maintains | 7 months ago |
Spyre Therapeutics IncSYRE | 5 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 1 | Hold | $65.00 | N/A | Maintains | a year ago |
Engene Holdings IncENGN | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Gracell Biotechnologies IncGRCL | 2 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Sangamo Therapeutics IncSGMO | 3 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Tectonic Therapeutic IncTECX | 1 | Strong Buy | $24.00 | N/A | Maintains | 2 years ago |
Alaunos Therapeutics IncTCRT | 1 | Strong Buy | $450.00 | N/A | Assumes | 2 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | $0.40 | N/A | Maintains | 3 years ago |
Argenx SeARGX | 1 | Hold | $326.00 | N/A | Maintains | 5 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $52.50 | N/A | Downgrades | 5 years ago |
Chemocentryx IncCCXI | 1 | Strong Buy | $79.00 | N/A | Initiates Coverage On | 5 years ago |
Global Blood Therapeutics IncGBT | 4 | Strong Buy | $133.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.